期刊文献+

小鼠canstatin及其N端片段在大肠杆菌BL21中的表达 被引量:2

Expression of Mouse canstatin and its N-domain in E.coli BL21
下载PDF
导出
摘要 以小鼠肝脏组织总RNA为模板,通过RT PCR扩增小鼠canstatin及其N端片段基因,克隆到pMD18 T载体中并进行序列分析。将小鼠canstatin及其N端片段基因定向克隆于原核表达载体pET30a(+)中,分别构建表达质粒pET/Can和pET/Can N,转化大肠杆菌BL21(DE3),IPTG诱导表达。结果表明:小鼠canstatin的cDNA长度为684bp,编码227个氨基酸,与已知的人canstatincDNA同源性为89%,氨基酸的同源性为96%。小鼠canstatinN端片段(1 95aa)与人的同源性为100%。IPTG诱导原核表达载体pET/Can和pET/Can N在大肠杆菌BL21(DE3)中的表达量约占菌体总蛋白量的35%和18%,重组蛋白主要以包涵体形式存在。文中报道的小鼠canstatin及其N端片段核苷酸序列已收入GenBank,接受号分别为:AY375463和AY502946。 The mouse canstatin and its N-domain cDNA were amplified from total RNA of mouse liver by RT- PCR and cloned into vector pMD18-T for sequencing. Prokaryotic expression vectors pET/Can and pET/Can-N were constructed and expressed in E.coli BL21(DE3) with induction of IPTG.Mouse canstatin cDNA is 684bp in length encoding 227 amino acids. The sequences of both cDNA and amino acids share high homology with human canstatin,with cDNA identity at 89% and amino acids identity at 96% to human canstatin. N-domain of mouse canstatin is the same amino acid sequence as that of human canstatin. In the present study,prokaryotic expression vector pET/Can and pET/Can-N were expressed in E.coli BL21 with amount of 35% and 18% of the total bacterial proteins after being induced by IPTG for 4h. The expressed products existed mainly as inclusion bodies. This work has laid down the basis for further study of its angiogenic activity and potential application for tumor dormancy therapy.
出处 《遗传》 CAS CSCD 北大核心 2004年第5期658-662,共5页 Hereditas(Beijing)
基金 国家自然科学基金项目(30270031) 河南省重大科技攻关项目0122032500) 河南省杰出人才创新基金(0221001900)~~
关键词 CANSTATIN 血管生成抑制素 RT-PCR CDNA克隆 canstatin angiogenesis inhibitor RT-PCR cDNA cloning prokaryotic expression
  • 相关文献

参考文献1

二级参考文献10

  • 1[1]Kamphaus GD, Colorado PC, Panka DJ, et al . Canstatin, anovel matrix - derived inhibitor of angiogenesis and tumorgrowth.[J] J Biol Chem, 2000,275(2):1209- 1215.
  • 2[2]Barinaga M. Desiging therapies that target tumor blood vessels[J]. Science, 1997, 275(5299) :482- 484.
  • 3[3]Haralabopoulos GC, Grant DS, Kleinman HK, et al. Inhibitorsof basement membrane collagen synthesis prevent endothelialcell aligment in matrigel in vitro and angiogenesis in vivo[J].Lab Invest , 1994,7 (4) : 575- 582.
  • 4[4]Timpl R. Macromolecular organization of basement membranes[J]. Curr Opin Cell Biol, 1996,8 (5):618 - 624.
  • 5[5]Tsilibary EC, Reger LA, Vogel AM.. et al . Identification of amultifunctional, cell binding peptide sequence from the αl(NCI) of tyre Ⅳ collagen[J]. J cell Biol, 1990,111 (4):1583- 1591.
  • 6[6]Neilson EG, Kalluri R, Sun MJ, et al. Specificity of goodpasture autoantibotidies for the recombinant noncollagenous domains of human type Ⅳ collagen[J]. J Biol Chem, 1993, 268(12):8402-8405.
  • 7[7]Brooks PC, Clark RA, Cheresh DA. Requirement of vascularintegrin alpha V beta 3 for angiogenesis[J]. Science, 1994,264 (5158): 569- 571.
  • 8[8]Chen YX,Nakashima Y,Tanaka K,et al. Immunohistochemicalexpression of vascular endothelial growth factor/vascular permeability factor in atherosclerotic intimals of human coronaryarteries[J]. ATVB, 1999, 19(1) :131 - 139.
  • 9[9]Moulton KS, Heller E, kinerding MA, et al. Angiogenesis inhibitors endostatin or TNP - 470 reduce intimal neovascularization and plaque growth in apoliipoprotein E - deficient mice[J]. Circulation, 1999,99 (13) :1726 - 1732.
  • 10[10]Tenaglia AN, Peters KG, Sketch MN, et al. Neovascularization in atherectomy specimens from patients with unstableangina: implications from pathogenesis of unstable angina[J].Am Heart J, 1998,135(1): 10 - 14.

共引文献5

同被引文献16

  • 1李玉英,钱桂生,黄桂君,王兴友,余时沧,李淑平,陈维中,戢福云.Canstatin基因表达载体的构建及其生物学效应研究[J].第三军医大学学报,2004,26(19):1723-1725. 被引量:12
  • 2Wei-HongHOU Tian-YunWANG Bao-MeiYUAN Yu-RongCHAI Yan-LongJIA FangTIAN Jian-MinWANG Le-XunXUE.Recombinant Mouse Canstatin Inhibits Chicken Embryo Chorioallantoic Membrane Angiogenesis and Endothelial Cell Proliferation[J].Acta Biochimica et Biophysica Sinica,2004,36(12):845-850. 被引量:17
  • 3Kamphaus GD, Colorado PC, Panka DJ, et al. canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth. J Biol Chem, 2000, 275(2): 1209-1215.
  • 4Habeck M. Wielding more power over angiogenesis. Mol Med Today. 2000. 6(4): 138-139.
  • 5He GA, Luo JX, Zhang TY, et al. The C-terminal domain of canstatin suppresses in vivo tumor growth associated with proliferation of endothelial cells. Biochem Biophys Res Commun, 2004, 318(2):354-360.
  • 6He GA, Luo JX, Zhang TY, et al. Expression and purification of the N-domain of human canstatin and its bioactivity. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai), 2003, 35(5):483-487.
  • 7He GA, Luo JX, Zhang TY, et al. canstatin-N fragment inhibits in vitro endothelial cell proliferation and suppresses in vivo tumor growth. Biochem Biophys Res Commun, 2003, 312(3): 801-805.
  • 8Panka DJ, Mier JW. canstatin inhibits Akt activation and induces Fas-dependent apoptosis in endothelial cells. J Biol Chem, 2003,278(39): 37632-37636.
  • 9Liu G, Guibao CD, Zheng J. Structural insight into the mechanisms of targeting and signaling of focal adhesion kinase. Mol Cell Biol, 2002, 22(8): 2751-2760.
  • 10Panka DJ, Mano T, Suhara T, et al. Phosphatidylinositol 3-kinase/Akt activity regulates c-FLIP expression in tumor cells. J Biol Chem, 2001, 276(10): 6893-6896.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部